Director and CEO
The Pirbright Institute

Prof Bryan Charleston obtained a BVetMed from the Royal Veterinary College, University of London, UK in 1982. After a period of time in Large Animal Practice, studied for a Masters degree in Molecular Biology at University College London in 1988, then a PhD degree, as a Wellcome Trust Scholar, from the University of London, UK, in 1991. He is currently the Director at the Pirbright Institute, UK. His research group’s efforts are focused on understanding the immune response to Foot-and–Mouth disease virus in cattle to develop novel vaccines. He was elected as a Fellow of the Royal Society in 2023.

Other speakers

Sven Arnouts Business Development Manager Ghent University - Provaxs
Klaus Hellmann Chief Veterinary Officer Argenta
Johannes Charlier Managing Director Kreavet
Nathalie Vanderheijden Coordinator fot the European Partnership on Animal Health and Welfare Ghent University
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Sebastiaan Theuns CEO & co-founder PathoSense
Dieter Vancraeynest External Innovation Zoetis
Beatrice Vos Partner Stonehaven Cozmix Group (SC Group)
Stewart Burgess Head of Department of Vaccines & Diagnostics Moredun Research Institute
Inne Xhonneux Project Advisor Life Sciences Flanders Innovation & Entrepreneurship (VLAIO)
Kazuhiko Hirose President and Representative Director Meiji Animal Health Co., Ltd.
Hanjo Hennemann Co-founder and CEO Verovaccines
Juerg Baggenstoss Partner Stonehaven Cozmix Group
Paul Dick Founder and President Paul Dick and Associates
Steve Nanchen Head External Innovation - R&D Elanco Animal Health
Erwin Blomsma CEO and Co-Founder Benno Therapeutics
Alfonso Martín-Fontecha Business Development Manager Laboratorios SYVA
Valerio Abbadessa Research Programme Officer EC DG AGRI, F2 R&I
Paul Horwood UK Head of Farm & Exports IVC Evidensia
Daisy Vanrompay Director of the Laboratory of Immunology and Animal Biotechnology Ghent University
Jennifer Serriere-Di Bartolo Biopharma Strategic Collaboration & Marketing Manager Promega
Jens Radzimanowski Director of Antibody Therapeutics Lead Identification Boehringer Ingelheim
Pieter-Jan Serreyn Technical Director AnimalhealthEurope
Charles Owen Founder and CEO 272Bio Limited
Jeremy Gowler Chief Executive Officer Ophirex, Inc.
Ralf Herold Head of Regulatory Science and Academia, Task force Regulatory Science and Innovation, EMA European Medicines Agency
Ivo Claassen Deputy Executive Director - Head of Veterinary Medicines Division European Medicines Agency
Jeroen Hofenk Founder & CSO SwiftPharma

Registrations are now open